Adapthealth Corp (AHCO)vsEdwards Lifesciences Corp (EW)
AHCO
Adapthealth Corp
$5.64
+1.26%
HEALTHCARE · Cap: $761.77M
EW
Edwards Lifesciences Corp
$86.29
+0.65%
HEALTHCARE · Cap: $50.87B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 94% more annual revenue ($6.51B vs $3.36B). EW leads profitability with a 15.4% profit margin vs -6.8%. EW earns a higher WallStSmart Score of 55/100 (C).
AHCO
Hold47
out of 100
Grade: D+
EW
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+67.3%
Fair Value
$32.23
Current Price
$5.64
$26.59 discount
Margin of Safety
+68.8%
Fair Value
$254.09
Current Price
$86.29
$167.80 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Strong operational efficiency at 29.8%
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 0.8%
Elevated debt levels
ROE of -16.6% — below average capital efficiency
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 25.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : AHCO
The strongest argument for AHCO centers on Price/Book. Revenue growth of 12.7% demonstrates continued momentum.
Bull Case : EW
The strongest argument for EW centers on Debt/Equity, Altman Z-Score, Market Cap. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.
Bear Case : AHCO
The primary concerns for AHCO are Market Cap, Operating Margin, Debt/Equity.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 52.5x leaves little room for execution misses.
Key Dynamics to Monitor
AHCO profiles as a turnaround stock while EW is a mature play — different risk/reward profiles.
AHCO carries more volatility with a beta of 1.39 — expect wider price swings.
EW is growing revenue faster at 13.6% — sustainability is the question.
EW generates stronger free cash flow (585M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 47/100), backed by strong 15.4% margins and 13.6% revenue growth. AHCO offers better value entry with a 67.3% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Adapthealth Corp
HEALTHCARE · MEDICAL DEVICES · USA
AdaptHealth Corp. The company is headquartered in Plymouth Meeting, Pennsylvania.
Visit Website →Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?